About
Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide.
Patients and caregivers
Information for patients and their caregivers including clinical trial recruiting, managed access programs, funding opportunities for patient organizations and side effects reporting.
Healthcare professionals
Resources for physicians and other healthcare professionals including clinical trial recruiting, grant funding, congresses and country-level information.
Research & development
Discover how Novartis turns breakthrough science into transformative, high-value treatments.
Environmental, social and governance
Learn about our commitments to making a positive impact on the world by providing access to innovative medicines, protecting the environment, and upholding high ethical standards. Explore the Novartis in Society Integrated Report.
Investors
Updates and resources for investors including financial information, disclosures, events, share price, ESG and reporting.
News
Information for journalists including media releases, statements, stories, multimedia resources and more.
Careers
Novartis is hiring! Find open positions, learn more about our strategy and culture, and apply today.
Home
Working together, we can reimagine medicine to improve and extend people’s lives.
04 Sep 2024 04:14:13 PM.@Novartis
We commit to the #RadioligandTherapy (RLT) demands of tomorrow by planning today. #ReimaginingMedicine https://t.co/kBTP4qrx2L
30 Aug 2024 11:06:42 AM.@Novartis
It is through research like the City Heartbeat Index and the greater understanding it brings that, together with our partners, we are better placed to support the development of targeted public health interventions based on individual needs of each city. https://t.co/oI4i9vJinj https://t.co/ZlOQgfNJCW
29 Aug 2024 10:26:02 AM.@Novartis
By understanding key drivers and barriers to heart health, we can collectively help people with #CardiovascularDisease enjoy longer, healthier lives. Discover how your city ranks https://t.co/oI4i9vJinj https://t.co/2kEjuWB8uq
22 Dec 2023 11:18:14 AM.@NovartisItalia
Il 2023 è stato un anno pieno di emozioni, tutte nate dal nostro impegno nel reimmaginare la medicina insieme. Ogni giorno, sempre di più, al fianco di tutti i partner della salute. Buone feste da tutto il team di #Novartis Italia! #Reimaginemedicinetogether https://t.co/PJaPKRQFua
21 Dec 2023 04:52:31 PM.@NovartisItalia
#Competenze è la parola scelta da Giulia Conti, Head of Innovation & Patient Journey di #Novartis Italia, per raccontarci il suo ruolo. Perché le competenze di chi vuole innovare sono varie e trasversali: la vera sfida è combinarle in base ai bisogni di interlocutori diversi,… https://t.co/FSv8DN2okZ https://t.co/xZjzKnOiP1
19 Dec 2023 07:05:22 PM.@NovartisItalia
Le chiavi per reimmaginare la #salute insieme sono almeno due secondo @francemoccia , Vice Segretaria generale di @Cittadinanzatti. Da un lato c'è la cultura della #prevenzione, perché con l'invecchiare della popolazione aumentano le patologie croniche. Dall'altro c'è… https://t.co/GWuijMClAm https://t.co/miHxQyNQ9F
29 Nov 2023 06:37:36 PM.@NovartisUK
Building your self-love and confidence every day is hard, but it is even harder, when you were just diagnosed with #BreastCancer. Read more about Tricia, Kirsten, Nina and Iyna’s take on beauty and identity this #BreastCancerAwarenessMonth in our feature with @marieclaire. Find… https://t.co/J26PVAp6C0 https://t.co/YQnCCLtU39
20 Nov 2023 03:01:02 PM.@NovartisUK
Last week, we were joined by @LizTwistMP as well as patient representatives, clinicians and other experts in #SpinalMuscularAtrophy, to discuss success factors for introducing SMA newborn screening to the UK. Here are our recommendations 👇 #NovartisOK https://t.co/PJyU4uGiUy
16 Nov 2023 06:01:04 PM.@NovartisUK
Last week, experts from across the #SpinalMuscularAtrophy community came together to discuss how we can accelerate the introduction of newborn SMA screening in the UK. Read more in our report - coming soon. #NovartisOK https://t.co/XgpK8vTVFS